Cited by 22Neurological Disorders and TreatmentsAcute Ischemic Stroke ManagementThyroid Disorders and Treatments

Reverse triiodothyronine (rT3) attenuates ischemia-reperfusion injury

Open access
Rastogi, Leena, Godbole, Madan M., Sinha, Rohit A., Pradhan, Sunil·2018·Biochemical and Biophysical Research Communications

Abstract

Hypothyroidism has been associated with better recovery from cerebral ischemia-reperfusion (IR) injury in humans. However, any therapeutic advantage of inducing hypothyroidism for mitigating IR injury without invoking the adverse effect of whole body hypothyroidism remains a challenge. We hypothesize that a deiodinase II (D2) inhibitor reverse triiodothyronine (rT3) may render brain specific hypometabolic state to ensue reduced damage during an acute phase of cerebral ischemia without affecting circulating thyroid hormone levels. Preclinical efficacy of rT3 as a neuroprotective agent was determined in rat model of middle cerebral artery occlusion (MCAO) induced cerebral IR and in oxygen glucose deprivation/reoxygenation (OGD/R) model in vitro. rT3 administration in rats significantly reduced neuronal injury markers, infarct size and neurological deficit upon ischemic insult. Similarly, rT3 increased cellular survival in primary cerebral neurons under OGD/R stress. Based on our results from both in vivo as well as in vitro models of ischemia reperfusion injury we propose rT3 as a novel therapeutic agent in reducing neuronal damage and improving stroke outcome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2018.10.031

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • T3 has an effect on glial morphology and hence on glial function in the adult brain; therefore, it also has an effect on neuron-glia interactions.

    “T3 has an effect on glial morphology and hence on glial function in the adult brain; therefore, it also has an effect on neuron-glia interactions. 115 , 116”

    From Major depressive disorder: hypothesis, mechanism, prevention and treatment (2024) · cites this paper as [116]

    The Results section on deiodinase expression reports that rT3 reduced glial D2 and increased neuronal D3, but does not address glial morphology or neuron–glia interactions. Searches for glial morphology, glial function, and neuron–glia interactions found no passage supporting the claim about T3 in the adult brain. Page numbers were not available in our copy. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rastogi, L., Godbole, M. M., Sinha, R. A., & Pradhan, S.
Affiliations
  • Babasaheb Bhimrao Ambedkar University (IN)
  • Sanjay Gandhi Post Graduate Institute of Medical Sciences (IN)
Corresponding author
Godbole, Madan M.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2018-11
Volume
506
Issue
3
Pages
597-603
ISSN
0006-291X (ISSN-L)
OpenAlex
W2896889098
Cited by
22
References
29
Citations by year
2025: 4 · 2024: 2 · 2023: 1 · 2022: 6 · 2021: 2 · 2020: 4 · 2019: 3
FWCI
1.01
Type
journal article
Language
en
Open access
Locations
  • Biochemical and Biophysical Research Communications (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • The Wellcome Trust DBT India Alliance (IA/I/16/2/502691)
  • Rochester Academy of Science (1592/DEL/2015)
  • Department of Science and Technology, Government of West Bengal (SR/WOS-A/LS-204/2007)
Topics
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Health Sciences › Medicine › Epidemiology › Acute Ischemic Stroke Management
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
Keywords
ischemia-reperfusion injury, cerebral ischemia, stroke, neuroprotection, hypothyroidism, middle cerebral artery occlusion, oxygen-glucose deprivation/reoxygenation, neuronal injury, infarct size, neurological deficit, thyroid hormone metabolism
MeSH terms
Animals, Blood Pressure, Cells, Cultured, Glucose, Heart Rate, Iodide Peroxidase, Male, Neurons, Triiodothyronine, Reverse, Reperfusion Injury, Rats, Sprague-Dawley, Oxidative Stress, Protective Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review